United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - perindopril erbumine - oral tablet - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - perindopril erbumine - oral tablet - 8mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 2 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; polacrilin potassium; silicon dioxide; hydroxypropylbetadex; colloidal anhydrous silica - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: silicon dioxide; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; polacrilin potassium; hydroxypropylbetadex - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: colloidal anhydrous silica; magnesium stearate; silicon dioxide; polacrilin potassium; hydroxypropylbetadex; microcrystalline cellulose - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 8mg

Canada - English - Health Canada

mantra pharma inc - perindopril erbumine - tablet - 2mg - perindopril erbumine 2mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

mantra pharma inc - perindopril erbumine - tablet - 4mg - perindopril erbumine 4mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

mantra pharma inc - perindopril erbumine - tablet - 8mg - perindopril erbumine 8mg - angiotensin-converting enzyme inhibitors